Substance use and medical outcomes in those age 50 and older involving cocaine and metamfetamine reported to United States poison centers
- PMID: 37083082
- PMCID: PMC10339160
- DOI: 10.1080/15563650.2023.2185494
Substance use and medical outcomes in those age 50 and older involving cocaine and metamfetamine reported to United States poison centers
Abstract
Context: Cocaine and metamfetamine use and overdose deaths among United States adults have been increasing in recent years. We examined associations of medical outcomes with co-used opioids and other substances among cocaine, and metamfetamine exposures in people age ≥50 years (N = 9300) reported to the National Poison Data System, 2015-2021.
Methods: We first described increases in these exposures over time. We fitted generalized linear models for a Poisson distribution with a log link, one for cocaine exposures and the other for metamfetamine exposures, to examine associations of medical outcomes (major effects/death versus all others) with co-used other substances, controlling for exposure year and demographics.
Results: The number of exposures increased steadily during the seven years, but metamfetamine exposures increased more rapidly starting in 2018. One-fifth of cocaine and one-sixth of metamfetamine exposures suffered major effects/death. Co-use of prescription opioids (incident risk ratio = 2.00, 95% CI = 1.76-2.28 for cocaine; incident risk ratio = 1.62, 95% CI = 1.27-2.07 for metamfetamine), illicit fentanyl (incident risk ratio =1.88, 95% CI = 1.08-3.27 for cocaine; incident risk ratio = 2.05, 95% CI = 1.04-4.06 for metamfetamine), heroin (incident risk ratio =1.62, 95% CI = 1.37-1.90 for cocaine), or amfetamine (incident risk ratio =1.73, 95% CI = 1.28-2.33 for cocaine) was associated with a higher likelihood of major effects/death.
Discussion: Increases in the number of cocaine and metamfetamine exposures among older adults reported to poison centers are of concern, and so is the increased risk of major effects/death from polysubstance use, especially prescription and illicit opioids, among these illicit psychostimulant users.
Conclusions: Healthcare provider screening of individuals at risk of cocaine and/or metamfetamine use and psychoeducation about the dangers of these substance use are needed.
Keywords: Poison centers; alcohol; cocaine; metamfetamine; older adults; opiates.
Conflict of interest statement
Conflict of interest
The authors declare no conflict of interest.
Figures



Similar articles
-
Cocaine-involved suspected suicide attempts in individuals age 50 and older reported to United States Poison Centers.Clin Toxicol (Phila). 2023 Aug;61(8):602-610. doi: 10.1080/15563650.2023.2244666. Epub 2023 Aug 16. Clin Toxicol (Phila). 2023. PMID: 37585276 Free PMC article.
-
Methamphetamine exposures reported to United States poison control centers, 2000-2019.Clin Toxicol (Phila). 2021 Aug;59(8):705-714. doi: 10.1080/15563650.2020.1861287. Epub 2021 Jan 6. Clin Toxicol (Phila). 2021. PMID: 33403876
-
Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021.Addiction. 2023 Dec;118(12):2477-2485. doi: 10.1111/add.16318. Epub 2023 Sep 13. Addiction. 2023. PMID: 37705148
-
Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.Clin Toxicol (Phila). 2010 Aug;48(7):695-708. doi: 10.3109/15563650.2010.516263. Clin Toxicol (Phila). 2010. PMID: 20849328 Review.
-
Stimulant misuse among youth.Curr Probl Pediatr Adolesc Health Care. 2022 Sep;52(9):101265. doi: 10.1016/j.cppeds.2022.101265. Epub 2022 Sep 29. Curr Probl Pediatr Adolesc Health Care. 2022. PMID: 36184490 Free PMC article. Review.
Cited by
-
Use, Effects, and Diagnostic Challenges of Cocaine Use in "Baby Boomers" and Older Adults.J Brown Hosp Med. 2023 Sep 15;2(4):87784. doi: 10.56305/001c.87784. eCollection 2023. J Brown Hosp Med. 2023. PMID: 40028298 Free PMC article. Review.
-
Global and regional burden of four drug use disorders in the elderly, 1990 to 2021: an analysis of the global burden of disease study.BMC Geriatr. 2025 Jul 2;25(1):434. doi: 10.1186/s12877-025-06075-5. BMC Geriatr. 2025. PMID: 40604442 Free PMC article.
References
-
- U.S. Department of Justice Drug Enforcement Administration. National drug threat assessment. 2021. Available from: https://www.dea.gov/sites/default/files/2021-02/DIR-008-21%202020%20Nati...
-
- Substance Abuse and Mental Health Services Administration. (2021). Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21–07-01–003, NSDUH Series H-56). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Available from https://www.samhsa.gov/data/
-
- Hedegaard H, Miniño AM, Warner M. Drug overdose deaths in the United States, 1999–2019. NCHS Data Brief, no 394. Hyattsville, MD: National Center for Health Statistics. 2020. Available from: https://www.cdc.gov/nchs/data/databriefs/db394-H.pdf - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical